Presentation is loading. Please wait.

Presentation is loading. Please wait.

The German model - a best practice example?“

Similar presentations


Presentation on theme: "The German model - a best practice example?“"— Presentation transcript:

1 The German model - a best practice example?“
"The value of Integrative Oncology in medicine: The German model - a best practice example?“ Peter Zimmermann MD, PhD Thomas Breitkreuz, MD Lunch Meeting with Dr.Thomas Ulmer, MEP 10th May 2011 European Parliament Strasbourg, Salon LOW IVAA, European Parliament, Strasbourg,

2 36 Akademische Zentren für Integrative Medizin in den USA

University of Arizona

Stanford University 
 University of California , Los Angeles 
 University of California, San Francisco

University of Colorado at Denver School of Medicine 

University of Connecticut Yale University 

University of Hawaii-Manoa 
John A. Burns School of Medicine 

Northwestern University Feinberg School of Medicine
 University of Illinois at Chicago School of Medicine

University of Kansas 

Johns Hopkins University
 University of Maryland Boston University School of Medicine 
Harvard Medical School 

Massachusetts Medical School

University of Michigan 

Mayo Clinic 
University of Minnesota 

University of Medicine and Dentistry of New Jersey 

University of New Mexico

Albert Einstein College of Medicine of Yeshiva University
 Carolina Duke University 
Forest University School of Medicine 

The Ohio State University

George Washington University 


 University of Wisconsin-Madison Oregon Health and Science University 

Thomas Jefferson University 
of Pittsburgh

Vanderbilt University

University of Texas Medical Branch 

University of Vermont College of Medicine 

University of Washington 

George Washington University 

University of Wisconsin-Madison 36 Akademische Zentren für Integrative Medizin in den USA 2009: NIH mit 294 Mill. USD Forschungsförderung für CAM i.S. der IM Deutschland: AM seit 20-er Jahren integrative Medizin!

3 2009: NIH mit 294 Mill. USD Forschungsförderung für CAM i.S. der IM
Deutschland: AM seit 20-er Jahren integrative Medizin!

4 Integrative Medicine: what should be integrated?
PATHOGENETIC CONCEPT focusses on pathogenesis physical / biochemical intervention biochemic blockade analytic / quantitatively orientated substance and space ideal: precise intervention addition von single factors “as much as necessary” SALUTOGENETIC CONCEPT focusses on healing process constitution / life style stimulation of processes holistic / qualitatively orientated process and time ideal: global dynamic combination / composition of effects „as much as possible“ Physikalische Intervention: OP /Koro / Vermeidung flachen Liegens bei Reflux.. Heilungsprozess: bedarf eines Begriffs der Gesundheit! Integrative Medizin: wesentlich ist die Integration von pathogenetisch orientierten und salutogenetisch orientierter Therapie Kardiovask: Mißverhältnis von salutogenet. Wissen und pathogenet. Praxis; Diskussion: wie genau bei welcher Erkrankung (Stellenwert) IVAA, European Parliament, Strasbourg,

5 Mrs A. J., 54 years, breast cancer
Case history Mrs A. J., 54 years, breast cancer History: Suffered breast cancer 4 years ago pT1b pN1 M0, PR+, ER+  Operation  Chemotherapy  Radiotherapy  Hormone therapy (Tamoxifen) – stopped due to side effects Presentation: Weakness / Fatigue Shortness of breath Weight loss: 7,5 kg / 5 months Case study from every day life in an anthroposophic hospital Aggressive treatment, common problem = fatigue (stays for years after chemotherapy) IVAA, European Parliament, Strasbourg,

6 Comes to our hospital. Looks for another treatment because of her long lasting fatigue from her first chemotherapy, feels to weak for a new one. IVAA, European Parliament, Strasbourg,

7 Why does she adress herself to an anthroposophic hospital
Why does she adress herself to an anthroposophic hospital? - Shown here: front page of the magazine of the german anthroposophic hospitals. Well known for oncologic treatment. - Patient´s support group. Looking for two features: double competence / experience in oncology. Problem of „oncologist and practitioner“ IVAA, European Parliament, Strasbourg,

8 http://www.anthromed.de/ Anthromed = hospital group.
Quality standards / quality control system. Transparent criteria offered to patients: what is AM? Fully integrated in health insurance system – all hospitals can admit every patient in germany and has to follow normal admission criteria. IVAA, European Parliament, Strasbourg,

9 Back to our patient – outpatient´s clinic.
Tretment starts with patient´s history – not only medical, but biographical. What is important for the patient? What does he or she suffers from? Patient´s preferences for treatment? Body and soul, biography? Start with diagnostic procedures IVAA, European Parliament, Strasbourg,

10 Mrs A. J., 54 years, relapse of breast cancer
Case history Mrs A. J., 54 years, relapse of breast cancer Findings in outpatient setting: Liver metastasis Elevated tumour markers Hospital admission: Examinations (radiographs, computer tomography, endoscopy...) Start constitutional (salutogenic) anthroposophic treatment (fatigue, appetite, anxiety / depression) Case study from every day life in an anthroposophic hospital Aggressive treatment, common problem = fatigue (stays for years after chemotherapy) IVAA, European Parliament, Strasbourg,

11 IVAA, European Parliament, Strasbourg, 10.5.11

12 IVAA, European Parliament, Strasbourg, 10.5.11

13 IVAA, European Parliament, Strasbourg, 10.5.11

14 Multimodal approach I: Medical intervention / Diagnostic tools
Intensive Care Endoscopy, catheterization, diagnostic interventions (i.e. biopsy techniques..) Oncology: Surgery provided, chemotherapy provided No difference to other hospitals Staff is well-trained with „double competences“ AM as an integrative, not „alternative“ medicine AM with 2 central features I want to point out: - Integrative treatment + multimodal approach

15 Mrs A. J., 54 years, relapse of breast cancer
Case history Mrs A. J., 54 years, relapse of breast cancer Findings in physical examinations: Liver metastases Pleural effusion causing shortness of breath Lymph node metastases (chest, abdomen) Other findings: Vitality: weakness / fatigue; disturbed sleep; difficulty to stand up and move; loss of appetite; disturbed circulation and heart rate Psychological: anxienty / depression Biographical: excessive demands at work / job strain; family conflicts; deep questions on meaning of life Increased fluid in the pleural space that sorrounds the lungs IVAA, European Parliament, Strasbourg,

16 Tumour board: as in other oncology departments and breast centres
AM: individualized recommendations, not only therapy standards; conventional AND AM treatment IVAA, European Parliament, Strasbourg,

17 Prognosis and treatment is discussed with patients and relatives
AM hospitals: rooms designed for dialogue / discussion about treatment / attandance / what it means to the family Palliative care! IVAA, European Parliament, Strasbourg,

18 Mrs A. J., 54 years, relapse of breast cancer
Case history Mrs A. J., 54 years, relapse of breast cancer Medical Treatment: Start with mistletoe therapy (first intravenously, continue with injections) Strengthen vitality with AM medicines (Levico comp. injections, Stibium met praep D6 intravenously, Hepatodoron Tablets Puncture of pleural effusion / mistletoe pleurodesis Start with hormone treatment (Femara) Nursing and physical therapies: Liver compresses with milfoil (common yarrow) extract Rhythmic massage Increased fluid in the pleural space that sorrounds the lungs IVAA, European Parliament, Strasbourg,

19 Most common salutogenic treatment for cancer in germany
As much as 70-80% of patients with breast cancer Problems with randomisation in studies; problems with large studies (cost of 20 million €) Here: homepage of doctor´s association with informations for patients and scientific information for doctors; independent from industry; HON-certified IVAA, European Parliament, Strasbourg,

20 Study data: overview of prospective studies (10/2010)
Prospective comparative studies 30 RCT´s, Σ = 3396 patients 18 N-RCT´s, Σ = 4068 patients Results: ✔ survival (OS) : 16 studies: significantly positive studies: positive trend studies without significant results ✔ QoL : 13 studies: significantly positive 2 studies: positive trend IVAA, European Parliament, Strasbourg,

21 Study data: overview of retrospective studies (10/2010)
Retrospective comparative studies 42 studies, Σ = 7571 patients parameter examinded: survival, QoL, remission / PFS, reduction of adverse effects of Cx / Rx Results: ✔ advantage mistletoe „overall“: 39/42 studies ✔ advantage mistletoe in high quality studies: 12/13 studies IVAA, European Parliament, Strasbourg,

22 Multimodal approach II: AM Medication
Wide range of AMP´s (>2000) Parenteral application of particular impor- tance (about 25% of total prescriptions) AM pharmaceuticals used in intensive care as well as for chronic disease Indication / selection: medical condition affected organs individual constitution process-related  „individualized therapy“

23 Pluralistic system in medicine: homgepage of the Federal institute....
Kommission C: market authorisation / pharmacovigilance / drug safety for AM (Homeopathy, Phytotherapy). NOT for Ayurveda / NOT for TCM (standards of production) IVAA, European Parliament, Strasbourg,

24 IVAA, European Parliament, Strasbourg,

25 Multimodal approach III: Nursing and physical therapies
Compresses Medical washings / medicinal baths (whole body, foot bath) Rhythmic massage (oil, ointment) Inhalation specific AM techniques AM pharmaceuticals for external use very effective in acute medical conditions differentiated therapy, not wellness!

26 Ingredients: sometimes teas / effusions, sometimes natural substances as bee wax
IVAA, European Parliament, Strasbourg,

27 Externals for compresses.
AMP´s needed for external use! Lack of regulation of externals in the EU. Externals for compresses. IVAA, European Parliament, Strasbourg,

28 Externals for massage. Highly differentiated therapeutic system!
In our hospital: every day use of about 80 different external AMPs IVAA, European Parliament, Strasbourg,

29 Mrs A. J., 54 years, relapse of breast cancer
Case history Mrs A. J., 54 years, relapse of breast cancer Active therapies: Eurythmy: movement therapy. Helps to activate healing forces, helps to overcome fatigue, find new active relation to own own physical vitality Art therapy (painting): express inner psychological dynamics, helps to find individual ways of coping with the disease IVAA, European Parliament, Strasbourg,

30 Multimodal approach IV: Art therapy / Eurythmy therapy
Art therapy: Painting / design Speech therapy Sculpture Music therapy Eurythmy therapy: movement therapy Patient is active in the healing process based on psycho-somatic interaction: creativity  impression and expression  physiological functions available in bedside setting

31 Mrs A. J., 54 years, relapse of breast cancer
Case history Mrs A. J., 54 years, relapse of breast cancer Hospital discharge after 12 days: Strengthened vitality, good appetite, regained 2 kg No shortness of breath, effective pleurodesis New ideas for every day life Learned mistletoe injection technique Course after 2 months: Rapidly growing lymph node metastasis Liver / lungs: stable Decision to start short course of chemotherapy in combination with whole-body-hyperthermia IVAA, European Parliament, Strasbourg,

32 Chemotherapy: outpatients department
Combination with anthroposophic medicines Warm surrounding is helpful IVAA, European Parliament, Strasbourg,

33 Case IVAA, European Parliament, Strasbourg,

34 Whole body hyperthermia: 38 – 40° - artificial fever
Infrared lamps and isolation beds Betters the outcome: Fever and immune stimulation effective in itself, part of AM therapies Combination with chemotherapy: antitumoral effect (tumour cells die, amplifies effects of Cx) IVAA, European Parliament, Strasbourg,

35 Warm feet, teas, cooling of head Duration: 3 hours
Monitoring Warm feet, teas, cooling of head Duration: 3 hours IVAA, European Parliament, Strasbourg,

36 Network oncology: own research and documentation; no funding by producers

37 IVAA, European Parliament, Strasbourg, 10.5.11

38 Mrs A. J., 54 years, relapse of breast cancer
Case history Mrs A. J., 54 years, relapse of breast cancer Chemotherapy / hyperthermia / mistletoe therapy: 3 months of treatment with 4 courses of epirubicin (3 week interval) Reduction of metastases (complete: liver; partial: lymph nodes) No side effects during therapy Continues AM therapy (mistletoe, constitutional, eurythmy therapy: Completely regained weight and vitality Active at work, changed every day life, positive attitude towards life Clinically stable since 3 years IVAA, European Parliament, Strasbourg,

39 Doctor´s team of my department
Postgraduate training centres for specialization in internal medicine / cardiology / oncology IVAA, European Parliament, Strasbourg,

40 Gliederung AM training in some universities; the best known is Witten / Herdecke Centre for new approaches in medical education Reforms of medical studies adapted by 8 other Universities / Medical Schools in Germany

41 IVAA, European Parliament, Strasbourg,


Download ppt "The German model - a best practice example?“"

Similar presentations


Ads by Google